Skip to main content
The recent failure of the PROMESA clinical trial for multiple system atrophy raises the question-are polyphenols a viable therapeutic option against proteinopathies?
- Author(s): Bitan, Gal
- et al.
Published Web Locationhttps://doi.org/10.21037/atm.2020.01.117
For improved accessibility of PDF content, download the file to your device.